Can Fite Biofarma Analyst Ratings
Can Fite Biofarma Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/24/2023 | 653.14% | HC Wainwright & Co. | $34 → $18 | Maintains | Buy |
| 06/02/2023 | 1322.59% | HC Wainwright & Co. | → $34 | Reiterates | → Buy |
| 03/13/2023 | 1322.59% | HC Wainwright & Co. | → $34 | Reiterates | → Buy |
| 06/24/2021 | 109.21% | Aegis Capital | → $5 | Initiates Coverage On | → Buy |
| 09/24/2019 | 25.52% | HC Wainwright & Co. | $30 → $3 | Maintains | Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 2023年10月24日 | 653.14% | HC Wainwright公司 | $34→$18 | 維護 | 買 |
| 06/02/2023 | 1322.59% | HC Wainwright公司 | →$34 | 重申 | →購買 |
| 03/13/2023 | 1322.59% | HC Wainwright公司 | →$34 | 重申 | →購買 |
| 06/24/2021 | 109.21% | 宙斯盾資本 | →$5 | 開始承保 | →購買 |
| 2019年09月24日 | 25.52% | HC Wainwright公司 | $30→$3 | 維護 | 買 |
What is the target price for Can Fite Biofarma (CANF)?
Can Fite Biofarma(CANF)的目標價格是多少？
The latest price target for Can Fite Biofarma (AMEX: CANF) was reported by HC Wainwright & Co. on October 24, 2023. The analyst firm set a price target for $18.00 expecting CANF to rise to within 12 months (a possible 653.14% upside). 3 analyst firms have reported ratings in the last year.
2023年10月24日，HC Wainwright&Co.報道了Can Fite Biofarma(美國證券交易所代碼：CANF)的最新目標價。這家分析公司將目標價定為18美元，預計CANF將在12個月內上漲至(可能上漲653.14%)。3家分析公司在過去一年公佈了評級。
What is the most recent analyst rating for Can Fite Biofarma (CANF)?
Can Fite Biofarma(CANF)的最新分析師評級是多少？
The latest analyst rating for Can Fite Biofarma (AMEX: CANF) was provided by HC Wainwright & Co., and Can Fite Biofarma maintained their buy rating.
對Can Fite Biofarma(美國證券交易所代碼：CANF)的最新分析師評級由HC Wainwright&Co.提供，Can Fite Biofarma維持買入評級。
When is the next analyst rating going to be posted or updated for Can Fite Biofarma (CANF)?
Can Fite Biofarma(CANF)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Can Fite Biofarma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Can Fite Biofarma was filed on October 24, 2023 so you should expect the next rating to be made available sometime around October 24, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括查閱公開財務報表，與Can Fite Biofarma的高管和客戶交談，以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。CAN Fite Biofarma的上一次評級是在2023年10月24日提交的，所以你應該預計下一次評級將在2024年10月24日左右的某個時候提供。
Is the Analyst Rating Can Fite Biofarma (CANF) correct?
分析師評級Fite Biofarma(CANF)是否正確？
While ratings are subjective and will change, the latest Can Fite Biofarma (CANF) rating was a maintained with a price target of $34.00 to $18.00. The current price Can Fite Biofarma (CANF) is trading at is $2.39, which is out of the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的CAN Fite Biofarma(CANF)評級保持不變，目標價在34.00美元至18.00美元之間。目前Can Fite Biofarma的交易價格為2.39美元，超出了分析師的預測區間。
譯文內容由第三人軟體翻譯。